Endogenous TCR promotes in vivo persistence of CD19-CAR-T cells compared to a CRISPR/Cas9-mediated TCR knockout CAR

Stenger D, Stief TA, Kaeuferle T, Willier S, Rataj F, Schober K, Vick B, Lotfi R, Wagner B, Gruenewald TGP, Kobold S, Busch DH, Jeremias I, Blaeschke F, Feuchtinger T (2020)

Publication Status: Published

Publication Type: Journal article, Original article

Publication year: 2020

Journal

Blood American Society of Hematology

Publisher: American Society of Hematology

Book Volume: 136

Pages Range: 1407-1418

Journal Issue: 12

DOI: 10.1182/blood.2020005185

Involved external institutions

Ludwig-Maximilians-Universität (LMU) DE Germany (DE) Deutsches Zentrum für Infektionsforschung (DZIF) DE Germany (DE) Deutsches Krebsforschungszentrum (DKFZ) DE Germany (DE) Klinikum der Universität München (Großhadern und Innenstadt) DE Germany (DE) Universitätsklinikum Ulm DE Germany (DE)

How to cite

APA:

Stenger, D., Stief, T.A., Kaeuferle, T., Willier, S., Rataj, F., Schober, K.,... Feuchtinger, T. (2020). Endogenous TCR promotes in vivo persistence of CD19-CAR-T cells compared to a CRISPR/Cas9-mediated TCR knockout CAR. Blood, 136(12), 1407-1418. https://dx.doi.org/10.1182/blood.2020005185

MLA:

Stenger, Dana, et al. "Endogenous TCR promotes in vivo persistence of CD19-CAR-T cells compared to a CRISPR/Cas9-mediated TCR knockout CAR." Blood 136.12 (2020): 1407-1418.

BibTeX: Download